Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01653093 · ClinicalTrials.gov registry record · NA

3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer

A NA study of Prostate Cancer, sponsored by University of Cincinnati.

Active
Registry status
NA
Development phase
280
Enrollment target
1
Study location

NCT01653093: Active NA study of Prostate Cancer, sponsored by University of Cincinnati.

NCT01653093 is a NA study of Prostate Cancer that is active but no longer recruiting, run by University of Cincinnati. The registered enrollment target is 280 participants, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (54% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01653093, a NA study of Prostate Cancer, is active but no longer recruiting, sponsored by University of Cincinnati.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
280 participants
Enrollment target
1
Study location

Study Summary

In standard clinical care, the prostate is imaged by magnetic resonance imaging (MRI) which is a procedure to take pictures of body structures by using a strong magnetic field and radio waves. The strength of the magnet used is expressed in the unit Tesla (T); a higher Tesla number means the magnet has stronger pull. Standard magnetic resonance imaging of the prostate uses a magnet 1.5 Tesla strong as well as a specialized endorectal coil (antenna) inserted into the body due to the limitations using an external body coil at this magnet strength. MRI using a 3 Tesla magnet has a theoretical advantage over imaging at 1.5 Tesla of creating a signal twice as strong that can be received by the antennas, resulting in better pictures. The goal of this study is to make the MRI procedure more comfortable for patients by using an external coil instead of an endorectal coil. With this study, researchers also want to help patients' health care teams, the surgeons in particular. Researchers will assess the impact of prostate MRI, without an endorectal coil, done at 3 Tesla and with an external body coil on helping doctors decide which approaches to disease therapy might be best for patients as well as correlate patients' study images with all other clinical imaging

Conditions Studied

Prostate Cancer

Interventions

  • PROCEDURE 3-Tesla magnetic resonance imaging (3T MRI)
  • PROCEDURE diffusion-weighted magnetic resonance imaging
  • PROCEDURE dynamic contrast-enhanced magnetic resonance imaging
  • PROCEDURE magnetic resonance spectroscopic imaging

Study Locations (1)

Ohio

  • The Ohio State University Medical Center, Stress - Columbus

Trial Details

FieldValue
Enrollment Target 280 participants
Start Date 2007-09-20
Est. Completion 2026-12-31
Phase NA

Sponsor

University of Cincinnati

245 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01653093

The ClinicalTrials.gov registry entry for NCT01653093 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 280 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 608-participant average among 735 other Prostate Cancer trials with a reported enrollment target (54% lower). The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Prostate Cancer appearing as the primary indexed condition, and to 4 interventions - of which 3-Tesla magnetic resonance imaging (3T MRI) is the first listed.

NCT01653093 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.

Frequently Asked Questions

What is clinical trial NCT01653093 about?

NCT01653093 is a clinical study titled "3-Tesla MRI in Finding Tumors in Patients With Known or Suspected Prostate Cancer". In standard clinical care, the prostate is imaged by magnetic resonance imaging (MRI) which is a procedure to take pictures of body structures by using a strong magnetic field and radio waves. The strength of the magnet used is expressed in the unit Tesla (T); a higher Tesla number means the magnet ...

What is the current status of trial NCT01653093?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 280 participants. The study started on 2007-09-20. Estimated completion is 2026-12-31.

What conditions does trial NCT01653093 study?

This clinical trial studies the following conditions: Prostate Cancer.

What interventions are being tested in trial NCT01653093?

The interventions under investigation include: 3-Tesla magnetic resonance imaging (3T MRI) (PROCEDURE), diffusion-weighted magnetic resonance imaging (PROCEDURE), dynamic contrast-enhanced magnetic resonance imaging (PROCEDURE), magnetic resonance spectroscopic imaging (PROCEDURE).

Who is sponsoring clinical trial NCT01653093?

This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01653093 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Prostate Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Prostate Cancer

All registered trials for this condition

Ohio

All trials with a study site in Ohio

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Related

Compare this shortlist side-by-side

Read our methodology - how this data is sourced, computed, and verified.
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.